Stocks and Investing Stocks and Investing
Mon, August 23, 2021
Fri, August 20, 2021

Aydin Huseynov Initiated (ATHE) at Buy and Held Target at $40 on, Aug 20th, 2021


Published on 2024-10-27 17:43:54 - WOPRAI, Aydin Huseynov
  Print publication without navigation


Aydin Huseynov of Benchmark, Initiated "Alterity Therapeutics Limited" (ATHE) at Buy and Held Target at $40 on, Aug 20th, 2021.

Aydin, nor any peers, have made any analyst calls on ATHE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources